The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients.
| Main Authors: | , , , , |
|---|---|
| Format: | Conference item |
| Published: |
2013
|
| _version_ | 1826298320307355648 |
|---|---|
| author | Barnett, G Flashman, E Kelly, D Schofield, C Gershlick, A |
| author_facet | Barnett, G Flashman, E Kelly, D Schofield, C Gershlick, A |
| author_sort | Barnett, G |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T04:45:02Z |
| format | Conference item |
| id | oxford-uuid:d2f461af-f36f-451c-8c47-e38d62a16931 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T04:45:02Z |
| publishDate | 2013 |
| record_format | dspace |
| spelling | oxford-uuid:d2f461af-f36f-451c-8c47-e38d62a169312022-03-27T08:07:51ZThe Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients.Conference itemhttp://purl.org/coar/resource_type/c_5794uuid:d2f461af-f36f-451c-8c47-e38d62a16931Symplectic Elements at Oxford2013Barnett, GFlashman, EKelly, DSchofield, CGershlick, A |
| spellingShingle | Barnett, G Flashman, E Kelly, D Schofield, C Gershlick, A The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients. |
| title | The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients. |
| title_full | The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients. |
| title_fullStr | The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients. |
| title_full_unstemmed | The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients. |
| title_short | The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients. |
| title_sort | prolyl hydroxylase inhibitor biq fg 2216 stabilises hif 1 alpha and upregulates vegf in vitro a potential strategy for difficult cto lesions in patients |
| work_keys_str_mv | AT barnettg theprolylhydroxylaseinhibitorbiqfg2216stabiliseshif1alphaandupregulatesvegfinvitroapotentialstrategyfordifficultctolesionsinpatients AT flashmane theprolylhydroxylaseinhibitorbiqfg2216stabiliseshif1alphaandupregulatesvegfinvitroapotentialstrategyfordifficultctolesionsinpatients AT kellyd theprolylhydroxylaseinhibitorbiqfg2216stabiliseshif1alphaandupregulatesvegfinvitroapotentialstrategyfordifficultctolesionsinpatients AT schofieldc theprolylhydroxylaseinhibitorbiqfg2216stabiliseshif1alphaandupregulatesvegfinvitroapotentialstrategyfordifficultctolesionsinpatients AT gershlicka theprolylhydroxylaseinhibitorbiqfg2216stabiliseshif1alphaandupregulatesvegfinvitroapotentialstrategyfordifficultctolesionsinpatients AT barnettg prolylhydroxylaseinhibitorbiqfg2216stabiliseshif1alphaandupregulatesvegfinvitroapotentialstrategyfordifficultctolesionsinpatients AT flashmane prolylhydroxylaseinhibitorbiqfg2216stabiliseshif1alphaandupregulatesvegfinvitroapotentialstrategyfordifficultctolesionsinpatients AT kellyd prolylhydroxylaseinhibitorbiqfg2216stabiliseshif1alphaandupregulatesvegfinvitroapotentialstrategyfordifficultctolesionsinpatients AT schofieldc prolylhydroxylaseinhibitorbiqfg2216stabiliseshif1alphaandupregulatesvegfinvitroapotentialstrategyfordifficultctolesionsinpatients AT gershlicka prolylhydroxylaseinhibitorbiqfg2216stabiliseshif1alphaandupregulatesvegfinvitroapotentialstrategyfordifficultctolesionsinpatients |